Bone mass and breast cancer risk in older women: Differences by stage at diagnosis

Journal of the National Cancer Institute

Volumn 93, Issue 12, 2001, Pages 930-936

  Zmuda, Joseph M ^a   Cauley, Jane A ^a   Ljung, Britt Marie ^c   Bauer, Douglas C ^b   Cummings, Steven R ^b   Kuller, Lewis H ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; AGE; AGED; ANAMNESIS; ARTICLE; BONE DENSITY; BONE MASS; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FOREARM; HEEL; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OBESITY; OSTEOPOROSIS; PHOTON ABSORPTIOMETRY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS; WRIST;

EID: 0035918842     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.12.930     Document Type: Article

References (50)

1. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer
2. The role of ovarian steroid hormones in mammary carcinogenesis
3. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women
4. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk
5. A prospective study of endogenous estrogens and breast cancer in postmenopausal women
6. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group
7. Binding of oestradiol to blood proteins and aetiology of breast cancer
8. Endogenous estrogen and postmenopausal breast cancer: A quantitative review
9. A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey
10. Serum sex hormone levels after menopause and subsequent breast cancer
11. Evidence of estrogen receptors in normal human osteoblast-like cells
12. Skeletal effects of estrogen
13. Association between low bone density and stroke in elderly women. The study of osteoporatic fractures
14. Non-trauma mortality in elderly women with low bone mineral density
15. Bone mineral density and risk of breast cancer in older women: The study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group
16. Bone mass and the risk of breast cancer among postmenopausal women
17. Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group
18. Manual for staging of cancer
19. Age-related decrements in bone mineral density in women over 65
20. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification
21. Reduced risk of breast and endometrial cancer among women with hip fractures (Sweden)
22. Reduced cancer morbidity and mortality in a prospective cohort of women with distal forearm fractures
23. Epidemiology and prevention of breast cancer
24. Axial and appendicular bone density predict fractures in older women
25. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
26. The effect of raloxifene on risk of breast cancer in post-menopausal women: Results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation
27. Continuing screening mammography in women aged 70 to 79 years: Impact on life expectancy and cost-effectiveness
28. The association of lifetime weight and weight control patterns with bone mineral density in an adult community
29. Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density
30. A woman's build and the risk of breast cancer
31. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls
32. Breast cancer risk assessed by anthropometry in the NHANES I epidemiological follow-up study
33. Anthropometric measures and metabolic rate in association with risk of breast cancer (United States)
34. Prospective study of height, body mass index and risk of breast cancer
35. Prospective study of relative weight, height, and risk of breast cancer
36. Height and weight in relation to breast cancer morbidity and mortality 1989. A prospective study of 570,000 women in Norway
37. Adolescence and breast carcinoma risk
38. A prospective study in general practice on breast-cancer risk in postmenopausal women
39. The association of height, weight, menstrual and reproductive events with breast cancer: Results from two prospective studies on the island of Guernsey (United Kingdom)
40. Osteoporosis
41. Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam Study
42. Perturbation by insulin of human breast cancer cell cycle kinetics
43. Insulin-like growth factors and bone: The osteoporosis connection revisited
44. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
45. The role of serum TGF-beta isoforms as potential markers of osteoporosis
46. The biology of growth regulation in normal and malignant breast epithelium: From bench to clinic
47. Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis
48. Increase in cytokine production (IL-1β, IL-6, TNF-α but not IFN-γ, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis
49. Interleukin-1α and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro
50. Interleukin-1α and tumor necrosis factor-α (TNFα) inhibit growth and induce TNF messenger RNA in MCF-7 human breast cancer cells